High USP22 expression indicates poor prognosis in hepatocellular carcinoma

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Ubiquitin-specific protease 22 (USP22) plays a role in histone regulation and gene transcription.
• USP22 expression is altered in various cancers.

Purpose of the Study:

• To investigate the expression and prognostic significance of USP22 in hepatocellular carcinoma (HCC).
• To evaluate USP22 as a potential molecular marker and therapeutic target in HCC.

Main Methods:

• Analysis of USP22 expression in HCC tissues and normal liver tissues.
• Correlation analysis between USP22 expression levels and clinical parameters (stage, grade).
• Kaplan-Meier survival analysis and multivariate analyses to assess prognostic value.

Main Results:

• USP22 expression was significantly higher in HCC tissues compared to normal liver tissues.
• Elevated USP22 expression correlated with advanced clinical stage and higher tumor grade in HCC.
• High USP22 expression was associated with poorer overall survival and recurrence-free survival.
• Multivariate analysis confirmed USP22 as an independent prognostic factor for HCC.

Conclusions:

• High USP22 expression is linked to tumor progression and poor prognosis in HCC.
• USP22 serves as a valuable independent molecular marker for predicting HCC outcomes.
• USP22 overexpression identifies high-risk HCC patients and represents a potential therapeutic target.